1. Home
  2. FLY vs RGEN Comparison

FLY vs RGEN Comparison

Compare FLY & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLY

Firefly Aerospace Inc.

HOLD

Current Price

$18.92

Market Cap

7.9B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$148.21

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLY
RGEN
Founded
2017
1981
Country
United States
United States
Employees
1409
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
6.6B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
FLY
RGEN
Price
$18.92
$148.21
Analyst Decision
Buy
Buy
Analyst Count
9
12
Target Price
$38.88
$167.67
AVG Volume (30 Days)
4.9M
947.4K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.15
Revenue
N/A
$141,236,000.00
Revenue This Year
$174.79
$14.30
Revenue Next Year
$66.73
$14.52
P/E Ratio
N/A
$988.20
Revenue Growth
N/A
35.10
52 Week Low
$16.00
$100.99
52 Week High
$62.17
$175.77

Technical Indicators

Market Signals
Indicator
FLY
RGEN
Relative Strength Index (RSI) 28.00 65.64
Support Level $18.07 $141.44
Resistance Level $21.93 $149.05
Average True Range (ATR) 2.02 4.96
MACD -0.41 0.30
Stochastic Oscillator 1.22 84.19

Price Performance

Historical Comparison
FLY
RGEN

About FLY Firefly Aerospace Inc.

Firefly Aerospace Inc is a space and defense technology company with an established track record of success providing comprehensive mission solutions to national security, government, and commercial customers. The company develops and provides space and defense technologies, including launch vehicles and spacecraft systems, supporting launch, transit, and in-orbit operations for government, commercial, and national security customers. It has only one operating segment. The majority of the company's revenue is derived from Spacecraft Solutions.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: